The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
Biosimilar medicines expand the biotherapeutic market and improve patient access. This work looked into the landscape of the European and US biosimilar products, their regulatory authorization, market availability, and clinical evaluation undergone prior to the regulatory approval. European Medicine...
Bewaard in:
| Hoofdauteurs: | , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI AG
2020-12-01
|
| Reeks: | Pharmaceutics |
| Onderwerpen: | |
| Online toegang: | https://www.mdpi.com/1999-4923/13/1/48 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|